Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug;15(4):e200486.
doi: 10.1212/CPJ.0000000000200486. Epub 2025 Jul 11.

Provider Experiences With Systematically Administered Patient-Reported Outcome Measures in Multiple Sclerosis: A Qualitative Sub-Study

Nathan Y Chu  1 , Aila Jamali  1 , Yazid N Al Hamarneh  2   3 , Kaitlyn E Watson  2   4 , Ross T Tsuyuki  2   3   5 , Penelope S Smyth  1
Affiliations

Provider Experiences With Systematically Administered Patient-Reported Outcome Measures in Multiple Sclerosis: A Qualitative Sub-Study

Nathan Y Chu et al. Neurol Clin Pract. 2025 Aug.

Abstract

Background and objectives: There has been interest in using patient-reported outcome measures (PROMs) to capture and systematically assess patients' perceptions of their multiple sclerosis (MS) experience and feed this information back to the clinician, but PROMs are not routinely used in MS outpatient clinics. We explored the perspectives of providers caring for persons with MS (PwMS) on the integration of PROMs into clinical practice.

Methods: This was a qualitative substudy of a separate randomized controlled trial (ClinicalTrials.gov: NCT0497954) examining the effect of PROM use on depression and anxiety levels in PwMS. We conducted semistructured interviews with 10 providers caring for participants enrolled in the study and explored their experiences using PROMs with PwMS. Thematic analysis through a mixed inductive and deductive approach was performed using verbatim interview transcriptions.

Results: Seven neurologists, 2 specialty MS nurse practitioners, and 1 MS registered nurse were interviewed. Providers expressed several facilitating factors with PROM usage, including engaging with patient-specific symptoms, initiating patient goal setting, and improving visit efficiency and patient satisfaction. However, providers also expressed barriers such as clinical workflow disruptions and technological barriers, skepticism toward the validity of results, and moral/ethical obligations to information gained from PROMs. Future opportunities elicited were the introduction of previsit PROMs and direct integration of PROMs into the electronic health record.

Discussion: From an MS provider's perspective, PROMs offer useful information but barriers continue to exist. PROMs have promise as an adjunct tool in the care of PwMS to optimize their functioning and experiences as health care system users, and these results may inform future strategic implementation of routine PROMs in MS clinics.

Trial registration information: This trial was registered on July 28, 2021, at the NIH United States National Library of Medicine, ClinicalTrials.gov. Clinical Trial ID: NCT04979546.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: N.Y.C. receives fellowship funding from the Canadian Network of Multiple Sclerosis Clinics (via unrestricted educational grants from EMD Serono, Sanofi Genzyme, Biogen, Hoffmann-La Roche and Novartis Pharmaceuticals Canada Inc.); and has received travel and accommodation funding from Alexion. R.T.T. has received arms-length investigator-initiated research grants from Sanofi, Merck, AstraZeneca, and Pfizer; and has been a consultant for Novo-Nordisk, Merck, Shoppers Drug Mart, and Emergent Biosolutions. P.S.S. receives grants/research support from Biogen Pharmaceuticals and MS Canada; and has received speakers bureau/honoraria/consulting fees from Novartis Pharmaceuticals, Roche Canada, STEDT, Biogen Idec Canada, EMD Serono, and Sanofi Genzyme Canada. The remaining authors have nothing to declare. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/cp.

References

    1. The Lancet Neurology. Patient-reported outcomes in the spotlight. Lancet Neurol. 2019;18(11):981. doi: 10.1016/S1474-4422(19)30357-6 - DOI - PubMed
    1. Black N. Patient reported outcome measures could help transform healthcare. BMJ. 2013;346:f167. doi: 10.1136/bmj.f167 - DOI - PubMed
    1. Sabah SA, Knight R, Alvand A, Beard DJ, Price AJ. Early patient-reported outcomes from primary hip and knee arthroplasty have improved over the past seven years: an analysis of the NHS PROMs dataset. Bone Joint J. 2022;104-B(6):687-695. doi: 10.1302/0301-620X.104B6.BJJ-2021-1577.R1 - DOI - PubMed
    1. Amato MP, Ponziani G, Rossi F, Liedl CL, Stefanile C, Rossi L. Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Mult Scler. 2001;7(5):340-344. doi: 10.1177/135245850100700511 - DOI - PubMed
    1. Abdelhak A, Antweiler K, Kowarik MC, et al. Patient-reported outcome parameters and disability worsening in progressive multiple sclerosis. Mult Scler Relat Disord. 2024;81:105139. doi: 10.1016/j.msard.2023.105139 - DOI - PMC - PubMed

Associated data

LinkOut - more resources